• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变:老龄化人群中日益受到关注的问题。

Diabetic retinopathy: a growing concern in an aging population.

作者信息

Paulus Yannis M, Gariano Ray F

机构信息

Stanford University School of Medicine, Stanford, Calif., USA.

出版信息

Geriatrics. 2009 Feb;64(2):16-20.

PMID:19256582
Abstract

Diabetic retinopathy--already the leading cause of irreversible blindness in working age Americans--is a rising threat as the diabetic population increases. Vision loss occurs due to retinal ischemia, retinal vascular exudation, intraocular hemorrhage, and ultimately, fibrotic complications. Optimal management of blood glucose levels and hypertension reduces the incidence and progression of retinopathy. Appropriate screening ensures early detection and management of diabetic retinopathy and reduces vision loss. Recent advances in our understanding of diabetic microvascular complications have led to new treatments that, along with refinements in laser and surgical techniques, are improving visual outcomes.

摘要

糖尿病视网膜病变——已然是美国劳动年龄人群不可逆失明的首要原因——随着糖尿病患者数量的增加,正构成日益严重的威胁。视力丧失是由视网膜缺血、视网膜血管渗出、眼内出血以及最终的纤维化并发症所致。血糖水平和高血压的优化管理可降低视网膜病变的发生率和进展。适当的筛查可确保早期发现和管理糖尿病视网膜病变,并减少视力丧失。我们对糖尿病微血管并发症认识的最新进展催生了新的治疗方法,这些方法与激光和手术技术的改进一起,正在改善视觉效果。

相似文献

1
Diabetic retinopathy: a growing concern in an aging population.糖尿病视网膜病变:老龄化人群中日益受到关注的问题。
Geriatrics. 2009 Feb;64(2):16-20.
2
Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy.玻璃体内曲安奈德和贝伐单抗作为糖尿病视网膜病变全视网膜光凝术的辅助治疗。
Br J Ophthalmol. 2010 Jul;94(7):858-63. doi: 10.1136/bjo.2009.168997.
3
Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.玻璃体内注射贝伐单抗(阿瓦斯汀)单独或联合曲安奈德与黄斑光凝术作为糖尿病性黄斑水肿的初始治疗方法比较
Retina. 2007 Nov-Dec;27(9):1187-95. doi: 10.1097/IAE.0b013e31815ec261.
4
[Treatment in diabetic maculopathy].
Oftalmologia. 2011;55(4):20-8.
5
Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.预防糖尿病性视网膜病变导致的失明。控制血糖和血压,并监测眼睛。
Prescrire Int. 2010 Feb;19(105):35-8.
6
Diabetic retinopathy in children.儿童糖尿病视网膜病变
Pediatr Endocrinol Rev. 2012;10(2):217-26.
7
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.糖尿病性视网膜病变。失明的筛查与预防。博士论文。
Acta Ophthalmol Scand Suppl. 1997(223):1-76.
8
Cataract surgery and diabetes.白内障手术与糖尿病。
Curr Opin Ophthalmol. 2010 Jan;21(1):4-9. doi: 10.1097/ICU.0b013e328333e9c1.
9
Diabetic retinopathy: An update on treatment.糖尿病视网膜病变:治疗进展。
Am J Med. 2010 Mar;123(3):213-6. doi: 10.1016/j.amjmed.2009.09.020.
10
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.一项关于玻璃体内注射贝伐单抗或激光治疗糖尿病性黄斑水肿的前瞻性随机试验(BOLT 研究)12 个月数据:报告 2。
Ophthalmology. 2010 Jun;117(6):1078-1086.e2. doi: 10.1016/j.ophtha.2010.03.045. Epub 2010 Apr 22.

引用本文的文献

1
Advances in Structural and Functional Retinal Imaging and Biomarkers for Early Detection of Diabetic Retinopathy.用于糖尿病视网膜病变早期检测的视网膜结构和功能成像及生物标志物的进展
Biomedicines. 2024 Jun 25;12(7):1405. doi: 10.3390/biomedicines12071405.
2
Adjunct Nondamaging Focal Laser Reduces Intravitreal Injection Burden in Diabetic Macular Edema.辅助性非损伤性局灶激光减轻糖尿病性黄斑水肿的玻璃体内注射负担
Photonics. 2023 Oct;10(10). doi: 10.3390/photonics10101165. Epub 2023 Oct 18.
3
Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial.
在糖尿病性黄斑水肿患者中玻璃体内注射贝伐单抗时加用外用酮咯酸的短期疗效:一项交叉随机临床试验
J Ophthalmic Vis Res. 2024 Mar 14;19(1):25-32. doi: 10.18502/jovr.v19i1.15424. eCollection 2024 Jan-Mar.
4
Eye Disease Prevalence and VF-14 Validation Among Patients Experiencing Homelessness and Presenting for Ophthalmic Examination in Baltimore, Maryland.马里兰州巴尔的摩市接受眼科检查的无家可归患者的眼病患病率和 VF-14 验证。
Transl Vis Sci Technol. 2023 Nov 1;12(11):7. doi: 10.1167/tvst.12.11.7.
5
Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema.与糖尿病性黄斑水肿患者视网膜内外层渐进性变薄速率相关的影像生物标志物和临床因素
Sci Rep. 2023 Feb 24;13(1):3224. doi: 10.1038/s41598-023-30432-2.
6
Factors Associated With the Presence of Foveal Bulge in Eyes With Resolved Diabetic Macular Edema.糖尿病性黄斑水肿消退后眼中存在黄斑隆起的相关因素。
Front Med (Lausanne). 2022 Jan 7;8:755609. doi: 10.3389/fmed.2021.755609. eCollection 2021.
7
Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment.老龄化人口中的糖尿病视网膜病变:发病机制和治疗的视角。
Clin Interv Aging. 2021 Jul 15;16:1367-1378. doi: 10.2147/CIA.S297494. eCollection 2021.
8
BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and Inflammation.BT2抑制人单核细胞-内皮细胞黏附、骨侵蚀和炎症。
J Inflamm Res. 2021 Mar 23;14:1019-1028. doi: 10.2147/JIR.S296676. eCollection 2021.
9
Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group.沙特阿拉伯糖尿病性黄斑水肿指南:沙特视网膜专家组的共识。
Saudi Med J. 2021 Feb;42(2):131-145. doi: 10.15537/smj.2021.2.25623.
10
The Role of Adrenoceptors in the Retina.肾上腺素受体在视网膜中的作用。
Cells. 2020 Dec 3;9(12):2594. doi: 10.3390/cells9122594.